Owens & Minor(NYSE:OMI) announced the earnings results for Fiscal Year 2016 and Q4. The results came in during After-Market on Feb 14, 2017. Based on the corporate Earnings and Guidance, many Investment Banking firms balance their portfolio to Sell and Buy Stocks based on their strategy of investing in stocks.Company reported revenue of $2.368B. Analysts estimated a revenue of $2.380B. The revenues were -0.5% below the estimates. Earnings per share were $0.52. The reported EPS was above estimates by 4%. Analysts had estimated an EPS of $0.5.
Owens & Minor (OMI) shares turned negative on Wednesdays trading session with the shares closing down -0.02 points or -0.06% at a volume of 7,86,486. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $36.25. The peak price level was also seen at $36.25 while the days lowest was $35.92. Finally the shares closed at $35.94. The 52-week high of the shares is $41.48 while the 52-week low is $30.43. According to the latest information available, the market cap of the company is $2,194 M.
Several Insider Transactions has been reported to the SEC. On Jan 24, 2017, Craig R Smith (director) sold 20,000 shares at $35.81 per share price.Also, On Nov 29, 2016, Charles C Colpo (SVP, Owens & Minor Europe Ops) sold 7,500 shares at $34.33 per share price.On Sep 1, 2016, Erika T Davis (SVP, Chief of Staff) sold 2,900 shares at $34.31 per share price, according to the Form-4 filing with the securities and exchange commission.
Owens & Minor Inc. is a healthcare logistics company. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products supplies and devices. The Company operates in two segments: Domestic and International. Domestic segment includes all functions in the United States relating to its role as a healthcare logistics company providing distribution packaging and logistics services to healthcare providers and manufacturers. International segment consists of its European third-party logistics and packaging businesses. It is focused on its operations on healthcare logistics services and provides its customers with a service portfolio that covers procurement inventory management delivery and sourcing of products for the healthcare market. Its customers include hospitals integrated healthcare systems group purchasing organizations manufacturers of life-science and medical devices and supplies including pharmaceuticals.